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Abstract
Background: Apoptosis is a major mode of hematological tumor death after radiation. Early
detection of apoptosis may be beneficial for cancer adaptive treatment. 99mTc-HYNIC-annexinV
has been reported as a promising agent for in vivo apoptosis imaging. The purpose of this study is
to evaluate the feasibility of in vivo99mTc-HYNIC-annexinV imaging of radiation- induced apoptosis,
and to investigate its correlation with radiosensitivity.
Methods: Ten days after inoculation of tumor cells in the right upper limbs, the mice were
randomly divided into two groups. The imaging group (4 mice each level, 4 dose levels) was injected
with 4-8 MBq 99mTc-HYNIC-annexinV 24 hours after irradiation and imaged 1 hr post-injection,
and the mice were sacrificed immediately after imaging for biodistribution analysis of annexin V.
The observation group (4 mice each level, 2 dose levels) was only observed for tumor regression
post-radiation. The number of apoptotic cells in a tumor was estimated with TUNEL assay.
Results: The  99mTc-HYNIC-annexin V uptake in E14 lymphoma significantly increased as the
radiation dose escalated from 0 to 8 Gy, and significantly correlated with the number of TUNEL-
positive cells (r = 0.892, P < 0.001). The Annexin-V uptake and the number of TUNEL-positive cells
in El4 lymphoma were significantly greater than those in S180 sarcoma. With 8 Gy, S180 sarcoma
tumor showed scanty apoptosis and less shrinkage while El4 lymphoma showed remarkable
apoptosis and complete remission.
Conclusion:  99mTc-HYNIC-annexinV in vivo imaging is a feasible method to detect early
radiation-induced apoptosis in different tumors, and might be predictive for radiation sensitivity.
Background
Apoptosis is a major mode of hematological tumor death
after ionizing irradiation and is closely correlated with
tumor sensitivity to radiation. The radiation induced
apoptosis can be classified as pre- and post-mitotic based
on the onset time [1,2]. Detecting the early phase of
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radiation-induced apoptosis is of special value for the pre-
diction of response to a certain treatment as well as for
early intervention with individualized treatment strate-
gies. At the early stage of apoptosis, the membrane-bound
lipid phosphatidylserine (PS), which is normally
restricted to the inner leaflet of the plasma membrane
lipid bilayer by an adenosine triphosphate-dependent
translocase, becomes exposed at the outer leaflet of the
plasma membrane bilayer [3]. Annexin V is an endog-
enous human protein and has a high affinity for mem-
brane-bound PS. The number of annexin V binding sites
per cell with the onset of apoptosis increases 100-to
1,000-fold during apoptosis. PS exposure on the cell sur-
face closely follows caspase-3 activation and occurs well
before DNA fragmentation. Therefore annexin V is a sen-
sitive marker of the early to intermediate phases of apop-
tosis. Human annexin V can be conjugated with
hydrazinonicotinamide (HYNIC) and radio-labeled with
99mTc to get 99mTc-HYNIC-annexin V, with a high labelling
rate and radiochemical purity and stability [4]. The In vivo
99mTc-HYNIC-annexinV apoptosis imaging has been
reported to be able to predict the severity of myocardium
infarction, organ transplantation rejection and response
to tumor chemotherapy treatment [5,6]. Encouraging
results were reported by some pilot studies [7,8] that early
phase 99mTc-HYNIC-annexin V scintigraphy (TAVS) after
radiotherapy in patients may be useful as a predictive test
for treatment response. However, the potential value of
99mTc-HYNIC-annexin V imaging in the evaluation of
radiation-induced apoptosis has yet to be established.
In order to evaluate the value of 99mTc-HYNIC-annexin V
imaging in detecting early phase apoptosis in tumors after
single dose irradiation and in predicting tumor response
to radiotherapy, a radiation murine tumor model was
established, and the relevance of TAVS image to apoptosis
and radiation sensitivity was explored.
Methods
Animals
Male C57BL/6 mice and Kunming mice were obtained
from the breeding facility of the Experimental Animal
Center, West China Medical Center, Sichuan University.
All mice were used between 6 and 12 weeks of age, and
weighed 18 to 22 g. Care of all experimental animals was
in accordance with institutional guidelines and approved
protocols.
Cell Culture Technique
The C57BL/6 mice derived EL4 lymphoma cell line was
obtained from the Transplantation Immunology Labora-
tory of West China Hospital, Sichuan University. The Kun-
ming mice derived S180 sarcoma cell line was obtained
from the Tumor Biotherapy Laboratory of West China
Hospital, Sichuan University. Both EL4 and S180 cell lines
were grown as cell suspensions in RPMI 1640 medium,
supplemented with 10% (v/v) fetal bovine serum and 290
μg/mL L-glutamine, 100 U/mL penicillin and 100 μg/mL
streptomycin. Cells were maintained in the logarithmic
growth phase at a concentration of 1-5 × 105 cells/mL at
37°C in a 5% CO2 in air atmosphere under aseptic condi-
tions.
Flow cytometry (FCM) assessment of apoptosis
Groups of EL4 lymphoma cells in logarithmic growth
phase were irradiated with a single dose of: 0 Gy, 2 Gy, 4
Gy or 8 Gy; the S180 sarcoma cells received only 0 Gy or
8 Gy. The 0 Gy group was served as the unirradiated con-
trol for both tumors. Irradiation was with 4 MV X-rays
generated by the Elekta Precise linear accelerator (Elekta,
Sweden) using 100 cm SSD,10 cm × 10 cm portal size,
with the cell culture flask lying on a 1.0 cm thick Perspex.
Twenty-four hours after irradiation, the samples were har-
vested and stained with Annexin V-FITC and PI for 15 min
at 25°C by using a commercial kit (BD Pharmingen,
USA). Cells were washed twice with PBS and re-suspended
in buffer solution (1 × 106 cells per ml). Stained cells were
analyzed with a flow cytometer (BD, FACSAria™) within 1
hour of staining, as described in the manufacturer's
manual.
Mouse bearing tumor model
The EL4 and S180 cells in logarithmic phase were har-
vested and washed three times with PBS, and re-sus-
pended in serum-free RPMI 1640 medium at a
concentration of 1.75 × 107cells per ml. A volume of 0.2
ml (3.5 × 106cells) tumor cell suspension was injected
subcutaneously ventral to the right axilla of the mice
(C57BL/6 for EL4, Kunming mice for S180). Mice were
monitored for tumor burden by measuring the tumor size
daily using a vernier calliper. Irradiation began when the
tumor diameter attained 1.0 cm.
Preparation of 99mTc-HYNIC-Annexin V
Human annexin V freeze-dried powder was purchased
from Beijing Huada Protein Development Center Co. Ltd
(Beijing, China). Human annexin V was conjugated with
hydrazinonicotinamide (HYNIC), using methods
described by Blankenberg et al. [5]. Derivatized HYNIC-
annexin V was radio-labelled with a 99mTc tricine precur-
sor complex according to literature methods [5,9-11].
After chelating with the 99mTc tricine precursor complex,
the radio-labeling efficiency was measured by using thin-
layer chromatography Silica Gel (TLC-SG), with methyl
ethyl ketone and normal saline as the developing solvent.
The radiochemical purity of the tracer product was then
measured with High Performance Liquid Chromatogra-
phy. The radio-labelled material, prepared as described
above, was diluted to have specific activities ranging from
400-800 MBq μg-1 1 ml-1 which was ready for use.Journal of Experimental & Clinical Cancer Research 2009, 28:136 http://www.jeccr.com/content/28/1/136
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Tumor irradiation
The tumor-bearing mice were randomly divided into an
imaging group which was irradiated and imaged using
99mTc-HYNIC-Annexin V, and an observation group
which was only observed for tumor regression after single-
dose irradiation. The EL4 lymphoma imaging group was
subdivided into 4 single-dose levels: 0, 2, 4, and 8 Gy,
while the S180 sarcoma imaging group received only 2
dose levels (0 and 8 Gy), with 4 mice each level. The
observation only groups of EL4 lymphoma and S180 sar-
coma both received the same dose levels of 0 Gy or 8 Gy
(4 mice each level). The tumors were irradiated with the 4
MV X-rays (SSD 100 cm, 1.5 cm × 1.5 cm portal) with a
0.5 cm thick tissue-equivalent material applied to the
tumor surface. The mice were anesthetized before irradia-
tion by intraperitoneal injection of 0.15 ml of 0.7%
pentobarbital and immobilized with tapes. Experiments
were repeated three times.
99mTc-HYNIC-annexin V imaging of radiation-induced 
apoptosis
At 24 hours after radiation, 0.2 ml (4-8 MBq) of the pre-
pared  99mTc-HYNIC-annexinV was injected into each
mouse in the imaging groups through the tail vein. Planar
images were obtained 2 hours later, using a single-head γ
camera (Meridian Philips Medical Systems) equipped
with a parallel-hole collimator. The energy window was
centered at 140 keV with a window width of 20%, and the
matrix was to 256 × 256 with a magnification factor of
3.0. The acquisition time was 1 min/image. The tumor
size of mice in the observation groups was measured daily
after irradiation.
Biodistribution of 99mTc-HYNIC-annexin V in tumors
Blood was drawn from the post-glomus venous plexus
immediately after 99mTc-HYNIC annexin V imaging and
mice were decapitated afterwards. The blood (B), the
tumor (T), and muscle (M) were excised from the mice
and weighed and then counted in a well-type γ Counter
(Xian Manufacture, China) for the evaluation of 99mTc-
annexin V biodistribution (energy peak at 140 keV and 10
s). The percentage of injected dose per gram of tissue
(%ID/g) was calculated. The T/M and T/B ratio were cal-
culated for correction of background radio-activity and
decay of 99mTc-HYNIC annexin V tracer.
Histocytochemical study of apoptosis in tumor tissue
Tumor apoptosis was assessed by in situ end-labelling of
DNA fragments (TdT-mediated dUTP-biotin nick end
labelling, TUNEL) using a commercially available kit
(Roche Applied Science). The fresh tumor tissue was fixed
in 10% formaldehyde for 24 hours, dehydrated, paraffin-
embedded and cut into 5- μm thick sections which were
subsequently mounted on slides, rehydrated before
stained with TUNEL for microscopic analysis. The mean
number of apoptotic cells was counted in 10 randomly
selected high-power fields.
Statistical analyses
Data were analyzed using the SPSS 13.0 software package.
All variables were expressed as mean (M) and standard
deviation (SD). All statistical comparisons of mean values
were performed with the F test (one-way ANOVA). Linear
correlation coefficients were calculated using a least
squares linear regression analysis. A significance level of P
< 0.05 was considered significant.
Results
Effect of different radiation doses on apoptosis in EL4 cells
The EL4 cells were irradiated in single-dose of 0, 2, 4 and
8 Gy groups, respectively. After irradiation, the cells were
maintained in suspension culture for 24 hours, and then
analyzed with FCM. As shown in Table 1, the EL4 cells had
spontaneous apoptosis even when no radiation was given
(0 Gy), and the number of apoptotic cells increased as
radiation dose was escalated from 2 to 8 Gy.
The apoptotic cell fractions (measured by FCM based on
Annexin V-FITC and propidium iodide (PI) staining) of
EL4 cells that received different single-irradiation doses (0
- 8 Gy) are shown in Figure 1. It shows that the number of
necrotic (Q1) and apoptotic cells (Q2+Q4, Q4 represents
the early phases of apoptosis) both significantly increased
as the radiation increased from 0 to 8 Gy.
In vivo 99mTc-HYNIC-annexin V imaging
The labelling efficiency of the HYNIC-annexin V sample
was 90%, with a radiochemical purity of 95%. Two hours
after injection of 0.2 ml of the prepared 99mTc-HYNIC
annexin (4-8 MBq), whole body planar imaging was per-
formed on tumor bearing mice which had received differ-
ent single-doses of radiation. As shown in Figures 2 and 3,
without radiation (0 Gy), the radioactivity uptake in EL4
lymphoma and S180 sarcoma was similar to that of the
background; the tumors were not clearly shown in 99mTc-
HYNIC-annexinV imaging. Moreover, the images in con-
trol animals (0 Gy) demonstrated a high concentration of
radio-labelled annexin V in the heart and bladder, with a
lesser distribution in other organs (Figures 2A and 3A).
The tracer uptake shows accumulation in the head and
Table 1: The change of apoptotic rate in EL4 lymphoma cells 
evaluated by FCM after different doses of 4 MV X-ray radiation
Dose(Gy) Apoptotic rate* (%)
0 3.13 ± 0.42
2 6.80 ± 0.20
4 12.60 ± 0.56
8 16.17 ± 0.85
*Value is expressed as Mean ± SD.Journal of Experimental & Clinical Cancer Research 2009, 28:136 http://www.jeccr.com/content/28/1/136
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neck and thymus region in EL4 lymphoma irradiated with
4 Gy and 8 Gy (Figures 2C and 2D). The increased density
of tracer in the tail (Figures 2A and 3B) was due to the
tracer at the site of injection. The liver and kidneys were
not visualized as separate structures. It demonstrated (Fig-
ures 2B to 2D) that for EL4 lymphoma, as the radiation
dose was escalated from 2 to 4 and 8 Gy, there was a
marked increase in tumor uptake of 99mTc-HYNIC
annexin V. The irradiated tumor image became clearer.
However, in S180 sarcoma bearing mice, even with 8 Gy
irradiation, the tumor uptake of 99mTc-HYNIC- annexin V
was similar to that of the background; and the tumor was
not clearly shown in imaging. The 99mTc-HYNIC- annexin
V uptake concentration was high in bladder, liver and
kidney.
Biodistribution of 99mTc-HYNIC- annexin V and tumor 
apoptosis after irradiation
The control and irradiated mice were sacrificed immedi-
ately after 99mTc-HYNIC-annexin V imaging. Biodistribu-
tion assays were performed with a well-type γ-counter.
The radioactivity parameters measured (T/M and T/B
ratios) are shown in Tables 2 and 3.
At 0 Gy (control), the percentage injected dose per gram
of tissue (%ID/g) in the tumor was low, with the T/B value
of (0.7294 ± 0.0365) for EL4 lymphoma and (0.4748 ±
0.0194) for S180 sarcoma, implying less uptake of tracer
in tumor than in the blood when unirradiated. However,
the T/M value was (2.5745 ± 0.1538) for EL4 lymphoma
and (1.2412 ± 0.0463) for S180 sarcoma, suggesting
greater tracer uptake in tumor than in muscle. It could
also be observed that the level of 99mTc-HYNIC-annexin V
uptake in control (0 Gy) tumor was much lower for S180
sarcoma than for EL4 lymphoma, implying lower sponta-
neous apoptosis in S180 sarcoma tumor compared to EL4
lymphoma.
Compared to the unirradiated control, the %ID/g in the
irradiated EL4 lymphoma increased 1.7 to 2.3 fold, the T/
B increased 1.7 to 2.3 fold, and T/M increased 2.0 to 2.8
fold, indicating increased uptake of 99mTc-HYNIC-
annexin V with irradiation and the increment was dose
dependent. As shown in Table 2, in EL4 lymphoma, the
uptake of 99mTc-HYNIC-annexin V significantly increased
as radiation dose rose from 0 to 8 Gy (P < 0.05).
On the contrary, in S180 sarcoma bearing mice, compared
to the 0 Gy control, the %ID/g, T/B and T/M with 8 Gy
irradiation only increased slightly (Table 3), indicating a
low level of apoptosis in S180 cells after radiation. For
S180 sarcoma, there were no significant differences in
%ID/g and T/B ratio between the 0 Gy and 8 Gy groups (P
> 0.05), but the T/M ratio in the 8 Gy group was signifi-
cantly higher than that of the 0 Gy group (P = 0.024), sug-
gesting higher uptake of tracer in blood but low level in
muscle.
Flow cytometry results for El4 lymphoma cells 24 hours after single-dose irradiation Figure 1
Flow cytometry results for El4 lymphoma cells 24 hours after single-dose irradiation. Using Annexin V-FITC and PI 
stain, it showed that the ratio of apoptotic cells increased with the escalation of dose. The abscissa represents the number of 
AnnexinV positive cells; the ordinate represents the number of PI positive cells. Q1 represents the necrotic cell potion, Q2: 
apoptotic cells; Q3: normal cells; Q4: early phase apoptotic cells.Journal of Experimental & Clinical Cancer Research 2009, 28:136 http://www.jeccr.com/content/28/1/136
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Comparing the radioactivity distribution in tumor
between EL4 lymphoma and S180 sarcoma bearing mice,
it was shown that for the same radiation dose (0 Gy and 8
Gy), the %ID/g, T/B and T/M of EL4 lymphoma were sig-
nificantly higher than those of the S180 sarcoma group
(both P < 0.001).
Correlation between apoptotic cell number and tracer 
uptake in tumor
The paraffin embedded tumor samples were stained for
apoptosis by TUNEL and studied under a light microscope
after biodistribution assay. TUNEL staining positive cells
demonstrated brown staining of the tumor cell nuclei
(Figures 4 and 5).
The degree of tracer uptake in tumor correlated well with
the apoptotic rate evaluated by TUNEL assay. In EL4 lym-
phoma, the apoptotic rate significantly increased as the
dose increased from 2 to 8 Gy (Table 2). In S180 sarcoma,
the apoptotic rate measured by TUNEL assay was signifi-
cantly higher in the 8 Gy group than that in 0 Gy group
(Table 3). Similar to the biodistribution results, the corre-
sponding apoptotic rate measured by TUNEL in the EL4
lymphoma was also significantly higher than that of the
S180 sarcoma for both 0 Gy (P = 0.017) and 8 Gy (P <
0.001). The increment of apoptotic cells at 8 Gy relative to
0 Gy was less in S180 sarcoma than that in the EL4 lym-
phoma, which agrees well with the TAVS imaging results.
As shown in Figure 6, when data from all tumor samples
were combined (EL4 and S180 tumors were not distin-
guished from each other), it could be observed that the
number of apoptotic cells (abscissa) was linearly corre-
lated with the percentage of 99mTc-HYNIC- annexin V
taken up by all tumors (ordinate), with a correlation coef-
ficient (r) of 0.892 and a corresponding P  value of <
0.001. These results indicated that the degree of radiation
induced apoptosis in tumor could be represented by the
99mTc-HYNIC- annexin V activity taken up in EL4 and
S180 tumors. However, there are systematic deviations of
points from the line, e.g., a sigmoid between 0.08 and
0.28 on the ordinate followed by a more gradual linear
increase between 2.8 and 4.
Tumor regression after irradiation
To evaluate the tumor response to radiation, the regres-
sion of EL4 lymphoma and S180 sarcoma in mice after
single-dose irradiation with 8 Gy was observed (Figure 7).
Without irradiation (0 Gy), the EL4 lymphoma grew with
a daily increment of 0.1 cm in diameter and reached 5.1
cc (SD = 1.1) 13 days after tumor inoculation in mice.
After a single 8 Gy irradiation, the EL4 lymphoma began
to shrink on the second day and the tumor underwent sig-
nificant necrosis on the 6th day after irradiation and disap-
peared completely on day 13.
Representative 99mTc-HYNIC-annexin V scintigraphy (TAVS)  images of EL4 lymphoma bearing mice treated with irradia- tion Figure 2
Representative 99mTc-HYNIC-annexin V scintigraphy 
(TAVS) images of EL4 lymphoma bearing mice 
treated with irradiation. Mice were injected 4-8 MBq 
radiolabeled annexin V 24 hours post-radiation and imaged 2 
h later. The images show increased annexin V uptake in 
tumor as radiation dose increased. The white arrow indi-
cates the implanted tumor. A: 0 Gy; B:2 Gy; C:4 Gy; D:8 Gy.
Annexin V imaging of S180 sarcoma bearing mice treated  with irradiation Figure 3
Annexin V imaging of S180 sarcoma bearing mice 
treated with irradiation. The images show insignificant 
annexin V uptake in tumor with radiation dose of 8 Gy com-
paring to 0 Gy control. The white arrow indicates the 
implanted tumor. A: 0 Gy; B:8 Gy.
   Journal of Experimental & Clinical Cancer Research 2009, 28:136 http://www.jeccr.com/content/28/1/136
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For S180 sarcoma, without irradiation, the mean tumor
volume grew to 3.2 cc (SD = 0.3) 13 days after inoculation
of tumor in mice. After a single 8 Gy irradiation, S180 sar-
coma mean volume showed minimal regression to 0.32 cc
(SD = 0.06) on day 12. The S180 tumor re-grew and
reached the pre-irradiation size on the 13th day after irra-
diation, suggesting loss of tumor control. The results
implied that with same dose irradiation, the EL4 lym-
phoma is more radiation-sensitive than S180 sarcoma.
Discussion
In this study, 99mTc-HYNIC-annexin V was conjugated and
radio-labelled, and successfully applied to image the radi-
ation-induced apoptosis in the murine tumor model. The
in vivo and in vitro dose response relationships of radia-
tion- induced apoptosis were analyzed. The in vivo apop-
tosis imaging was compared between two tumors with
different radiation responsiveness.
The  99mTc-HYNIC-annexin V imaging showed that the
physiologic uptake of 99mTc-HYNIC-Annexin V was
mainly in the heart, kidneys, bladder, liver and spleen.
The accumulation of the tracer in the head and neck and
thymus in EL4 lymphoma-bearing mice at 4 and 8 Gy was
significant. This was assumed to be due to increased radi-
ation scatter to the tissues near the tumor providing
greater radiation doses, thus resulting in increased apop-
tosis. Our results are consistent with those described in
the literature, in which the tracer density in the thymus of
an EL4 thymoma murine model was also elevated [12].
However, the high tracer uptake in head and neck or thy-
mus was not observed in the Kunming mice bearing S180
sarcoma, indicating different normal tissue responses of
two mouse strains.
Our results showed that at 24 hours, 99mTc-HYNIC-
annexin V imaging can show clearly the early phase apop-
tosis after single-dose irradiation. In this study, TUNEL
staining was chosen to measure apoptosis rate, following
the successful reports on its predictive value for apoptosis
from other studies [[5,7,11], and [12]]. In both EL4 and
S180 tumors, the number of apoptotic cells measured by
TUNEL assay was positively correlated with the uptake of
Table 2: Biodistribution of 99mTc-HYNIC-Annexin-V in EL4 lymphoma and the number of apoptotic cells after single-dose irradiations
Dose (Gy) p
02480  v s . 2 2  v s . 4 4  v s . 8
%ID/g 0.160 ± 0.013 0.272 ± 0.021 0.312 ± 0.020 0.355 ± 0.025 <0.001 0.017 0.009
T/B 0.729 ± 0.037 1.252 ± 0.086 1.396 ± 0.021 1.661 ± 0.072 <0.001 0.005 <0.001
T/M 2.575 ± 0.154 4.522 ± 0.554 5.191 ± 0.511 7.138 ± 0.266 <0.001 0.039 <0.001
Apoptotic cells 1.405 ± 0.191 2.459 ± 0.370 4.364 ± 0.778 6.953 ± 0.673 0.002 0.004 0.002
Results expressed as mean ± SD. %ID/g = percentage injected dose per gram of tumor tissue; T: 99mTc-HYNIC annexin-V uptake in tumor; B: 
99mTc-HYNIC-annexin V uptake in blood; M: 99mTc-HYNIC annexin-V uptake in muscle. Apoptotic cells were counted as the number of TUNEL 
positive cells per mm2 of each examined section.
Table 3: Biodistribution of 99mTc-HYNIC-Annexin-V in S180 
sarcoma and the number of apoptotic cells after single-dose 
irradiations
Dose (Gy)
08 p
%ID/g 0.097 ± 0.008 0.102 ± 0.008 0.464
T/B 0.475 ± 0.019 0.465 ± 0.031 0.608
T/M 1.241 ± 0.046 1.501 ± 0.167 0.024
Apoptotic cells 0.740 ± 0.362 1.627 ± 0.121 0.004
The abbreviations: the same as in Table 2.
TUNEL assay for EL4 transplant lymphoma after irradiation Figure 4
TUNEL assay for EL4 transplant lymphoma after 
irradiation. In pathological sections (× 100) of EL4 trans-
plant lymphoma after single-dose irradiation, the black arrow 
indicates the TUNEL positive apoptotic cells. It shows that 
the number of apoptotic cells increase as the radiation dose 
is escalated from 0 to 8 Gy.Journal of Experimental & Clinical Cancer Research 2009, 28:136 http://www.jeccr.com/content/28/1/136
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radio-labeled annexin V (Figure 6), suggesting that the
application of 99mTc-HYNIC-annexin V to evaluate early-
phase radiation-induced apoptosis is feasible. The obser-
vation is consistent with the literature report that external-
ization of PS in cell membrane might appear as early as 1
to 5 hours after injury stimulation, but only the PS exter-
nalization at 9 to 24 hours was related to apoptosis [13].
Moreover, if detected later, the sensitivity of PS to predict
apoptosis would be reduced due to the clearance of PS
expression cells by macrophages [14,15]. Our results agree
well with those of a reported study [12] that also corre-
lated TUNEL assay with 99mTc-HYNIC-annexin V uptake
in a murine thymoma model to evaluate tumor response
after radiation or cytotoxic drug treatment. It was postu-
lated that 99mTc-HYNIC-Annexin V may be an ideal agent
for imaging of early apoptosis in response to treatment.
Mochizuki et al. [11] has similarly found in a KDH-8 liver
cancer murine model that annexin V imaging could accu-
rately image the cyclophosphamide induced early apopto-
sis. However, in our study, as shown in Figure 6, the steep
change in the 0.1 to 0.28 region poses some constraints
on using this regression to predict %D/g from TUNEL pos-
itive cells, or vice versa.
Our study demonstrated that the early phase apoptosis
induced by radiation is dose dependent, and 99mTc-
HYNIC-annexin V imaging can reflect this dose-response
relationship. In EL4 lymphoma, the number of apoptotic
cells detected by TUNEL in irradiated groups increased as
radiation dose rose and was 1.7 to 4.9 times that of the
un-irradiated groups. Within the same tumor tissue, the
TUNEL results correlated well with the in vivo annexin V
radioactivity which in the irradiated groups' uptake was
also 1.7 to 4.9 times that in the un-irradiated tumors.
Though we did not quantify the 99mTc-HYNIC-annexin V
uptake in TAVS, it could be visualized clearly that the
intensity of tracer increased as the radiation dose escalated
(Figures 2 and 3). Yong et al. [16] also reported similarly,
on a murine breast tumor model, that it is feasible to use
99mTc-EC-annexin to image early tumor apoptosis. Our
results are consistent with a study reported by Liu [17].
TUNEL assay for S180 transplant sarcoma after irradiation Figure 5
TUNEL assay for S180 transplant sarcoma after irra-
diation. In pathological sections of S180 sarcoma after irra-
diation (× 100), the black arrow indicates the TUNEL 
positive apoptotic cells. It shows that the number of apop-
totic cells increases as radiation of 8 Gy is delivered compar-
ing to that of the 0 Gy control.
 
Correlation of TUNEL positive cells and 99mTc-HYNIC- annexin V uptake in EL4 and S180 tumors Figure 6
Correlation of TUNEL positive cells and 99mTc-
HYNIC-annexin V uptake in EL4 and S180 tumors. 
The plot shows the number of apoptotic cells (TUNEL posi-
tive) is linearly correlated with the uptake of the radio-
labeled Annexin-V in the murine transplant tumors, showing 
that the Annexin-V imaging may illustrate different degrees of 
radiation induced apoptosis.
Semilog plot of tumor regression in EL4 and S180 tumors  after 8 Gy single-dose irradiation Figure 7
Semilog plot of tumor regression in EL4 and S180 
tumors after 8 Gy single-dose irradiation. The tumor 
volume (cc) in logarithmic scale (ordinate) is plotted against 
days (abscissa) after radiation. The unirradiated EL4 (EL4 0 
Gy) and S180 (S180 0 Gy) controls show exponential 
growth. EL4 lymphoma is more radiation sensitive with a 
complete regression, while S180 sarcoma is less radio-sensi-
tive which slightly shrank after radiation and relapsed at 13th 
day.
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However the positive correlation between early phase
apoptosis and radiation dose is considered only applica-
ble within a limited dose range [18]. Recent findings have
been reported that large single dose irradiation (8 to 15
Gy) may enhance tumor radiation sensitivity through the
induction of tumor blood vessel endothelium apoptosis
[19,20].
Our study also illustrated that the degree of early phase
apoptosis after irradiation might be correlated with tumor
radiation sensitivity. When receiving the same irradiation
dose, the EL4 lymphoma and S180 sarcoma responded
differently. With a single 8 Gy irradiation, the EL4 tumor
was completely controlled after radiation. This is consist-
ent with the finding that El4 lymphoma is sensitive to
radiation and usually undergoes P53 dependent apopto-
sis after radiation [21]. However, the S180 sarcoma was
comparatively irradiation resistant as the tumor in this
study remained stable for a short time after the same radi-
ation dose and eventually relapsed. Meanwhile, after the
same 8 Gy dose, the uptake of radio-labeled annexin V as
well as the number of apoptotic cells detected by TUNEL
in S180 sarcoma tumor was significantly lower than that
in EL4 lymphoma, indicating that the different response
to radiation between these two tumor types might be cor-
related with the difference in early phase apoptosis. Our
study had a similar observation as that reported in the lit-
erature [7,8] that 99mTc-HYNIC-annexin V accumulation
correlated well with tumor response after radiotherapy in
different tumor types. As this is a feasibility study, whether
detection of apoptosis by 99mTc-HYNIC-annexin V imag-
ing might predict tumor radiation-sensitivity needs fur-
ther validation.
In addition, the number of apoptotic cells at 0 Gy (with-
out irradiation) was higher in EL4 tumor than in S180 sar-
coma, indicating that the rate of spontaneous apoptosis in
EL4 lymphoma is higher than that in S180 sarcoma.
According to our results, the difference in spontaneous
apoptosis was also positively correlated with the differ-
ence in degree of radiation-induced apoptosis. This sug-
gested that pre-treatment spontaneous apoptosis might
predict the apoptotic radiation response as well. Dubray
also came to similar conclusions after studying the rela-
tionship between spontaneous and radiation-induced
apoptosis with radiotherapy outcome in non-Hodgkin's
lymphoma [22]. Rottey et al [23] utilized 99mTc-HYNIC-
annexin V imaging in head and neck squamous carci-
noma to evaluate apoptosis before treatment, and found
that spontaneous apoptosis in tumor could predict tumor
response to treatment. Recently annexin V imaging has
begun to be applied in patients' receiving head and neck
tumor radiotherapy, but the significance is not clear and
needs further investigation [24].
Conclusion
Results of this preliminary study indicated that 99mTc-
HYNIC-annexin V imaging might provide a possible
means of in vivo prediction of tumor response to radia-
tion. The degree of early phase accumulation of 99mTc
HYNIC-rh-annexin V in tumor after single dose radiation
implied radiation-induced apoptosis and radio-respon-
siveness. On the contrary, the tumor with no significant
accumulation of 99mTc HYNIC-rh-Annexin V implies poor
response to radiotherapy.
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